Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)

Skip to main content

Phase: II/III
Status: Not Recruiting

The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Aortic Valve Replacement (SAVR) or TAVI with the Medtronic CoreValve® System.

Principal Investigator

James Joye, DO

Sponsor

Medtronic Cardiovascular

NCT Number

NCT01586910

Contact

Kara Turner, Clinical Research Coordinator
Taft Center for Clinical Research
650-962-4562
kara_turner@elcaminohealth.org

For more information about this clinical trial, including trial status, eligibility and full trial listing, visit www.clinicaltrials.gov.